TI
LYRA

Trexquant Investment’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Trexquant Investment’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-222
Closed -$101K – 1487
2021
Q3 		$101K Sell
222
-10
-4% -$3.78K 0.01% 1051
2021
Q2 		$93K Buy
+232
New +$106K 0.01% 1018

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Trexquant Investment's LYRA Position: Q4 2021 in Review

Trexquant Investment sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2021, closing a stake of 222 shares — an estimated $101K sold.

Trexquant Investment first reported a position in LYRA in Q2 2021 and held it in 2 quarters. The position peaked at $101K in Q3 2021. 33 funds tracked by Wall St. Rank hold LYRA as of Q4 2021.

  • Trexquant Investment reported no remaining LYRA THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Trexquant Investment sold 222 LYRA THERAPEUTICS INC shares in Q4 2021, an estimated $101K.
  • Trexquant Investment first reported a position in LYRA THERAPEUTICS INC in Q2 2021 and held it in 2 quarters.
  • Trexquant Investment's LYRA THERAPEUTICS INC position peaked at $101K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2021.

Based on Trexquant Investment's 13F filing for Q4 2021, filed 14 Feb 2022.